Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Bucolo

Showing results (41-50 of 201) with videos related to

Pageof 21
Sort By:
Experimental Eye Research|August 8, 2024
Targeting the PINK1/Parkin pathway: A new perspective in the prevention and therapy of diabetic retinopathyAgata Grazia D'Amico, Grazia Maugeri, Benedetta Magrì, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 13, 2002
Eudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofenRosario Pignatello, Claudio Bucolo, Piera Ferrara, et al.
AAPS Pharmscitech|April 6, 2006
Preparation and characterization of eudragit retard nanosuspensions for the ocular delivery of cloricromeneRosario Pignatello, Nadia Ricupero, Claudio Bucolo, et al.
Peptides|June 23, 2012
Early changes in pituitary adenylate cyclase-activating peptide, vasoactive intestinal peptide and related receptors expression in retina of streptozotocin-induced diabetic ratsSalvatore Giunta, Alessandro Castorina, Claudio Bucolo, et al.
AAPS Pharmscitech|March 15, 2017
Preparation and characterization of Eudragit Retard nanosuspensions for the ocular delivery of cloricromeneRosario Pignatello, Nadia Ricupero, Claudio Bucolo, et al.
Investigative Ophthalmology & Visual Science|October 1, 2010
In vivo ocular efficacy profile of mapracorat, a novel selective glucocorticoid receptor agonist, in rabbit models of ocular diseaseAfshin Shafiee, Claudio Bucolo, Ewa Budzynski, et al.
Cornea|January 25, 2008
Chitinase levels in the tears of subjects with ocular allergiesMaria Musumeci, Milena Bellin, Adriana Maltese, et al.
Frontiers in Pharmacology|February 17, 2025
Corneal protective effects of a new ophthalmic formulation based on vitamin B12 and sodium hyaluronateFrancesca Lazzara, Federica Conti, Grazia Maugeri, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|June 27, 2007
Hemin, an inducer of heme oxygenase-1, lowers intraocular pressure in rabbitsMaria G Privitera, Marta Potenza, Claudio Bucolo, et al.
The Journal of Pharmacy and Pharmacology|July 6, 2004
Eudragit RL100 nanoparticle system for the ophthalmic delivery of cloricromeneClaudio Bucolo, Adriana Maltese, Francesco Maugeri, et al.
Pageof 21

Showing results (41-50 of 201) with videos related to

Sort By:
Pageof 21
Experimental Eye Research|August 8, 2024
Targeting the PINK1/Parkin pathway: A new perspective in the prevention and therapy of diabetic retinopathyAgata Grazia D'Amico, Grazia Maugeri, Benedetta Magrì, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 13, 2002
Eudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofenRosario Pignatello, Claudio Bucolo, Piera Ferrara, et al.
AAPS Pharmscitech|April 6, 2006
Preparation and characterization of eudragit retard nanosuspensions for the ocular delivery of cloricromeneRosario Pignatello, Nadia Ricupero, Claudio Bucolo, et al.
Peptides|June 23, 2012
Early changes in pituitary adenylate cyclase-activating peptide, vasoactive intestinal peptide and related receptors expression in retina of streptozotocin-induced diabetic ratsSalvatore Giunta, Alessandro Castorina, Claudio Bucolo, et al.
AAPS Pharmscitech|March 15, 2017
Preparation and characterization of Eudragit Retard nanosuspensions for the ocular delivery of cloricromeneRosario Pignatello, Nadia Ricupero, Claudio Bucolo, et al.
Investigative Ophthalmology & Visual Science|October 1, 2010
In vivo ocular efficacy profile of mapracorat, a novel selective glucocorticoid receptor agonist, in rabbit models of ocular diseaseAfshin Shafiee, Claudio Bucolo, Ewa Budzynski, et al.
Cornea|January 25, 2008
Chitinase levels in the tears of subjects with ocular allergiesMaria Musumeci, Milena Bellin, Adriana Maltese, et al.
Frontiers in Pharmacology|February 17, 2025
Corneal protective effects of a new ophthalmic formulation based on vitamin B12 and sodium hyaluronateFrancesca Lazzara, Federica Conti, Grazia Maugeri, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|June 27, 2007
Hemin, an inducer of heme oxygenase-1, lowers intraocular pressure in rabbitsMaria G Privitera, Marta Potenza, Claudio Bucolo, et al.
The Journal of Pharmacy and Pharmacology|July 6, 2004
Eudragit RL100 nanoparticle system for the ophthalmic delivery of cloricromeneClaudio Bucolo, Adriana Maltese, Francesco Maugeri, et al.
Pageof 21